Development and validation of a broad-based second generation multi marker “Morphometric IHC” test for optimal treatment planning of Stage 1 and 2 IDC Breast patients: Beyond ER, PR, Her2 and Ki67

Fri, 10 February 2017 13:30
by Dr Manjiri Bakre (OncoStem Diagnostics Pvt Ltd)
Venue: GIS Seminar Area, Level 2, Genome Building